(Q37069199)

18 August 2017

1 reference

title

Restless legs syndrome induced by escitalopram: case report and review of the literature (English)

1 reference

18 August 2017

1 reference

restless legs syndrome

1 reference

1 reference

Robert Lee Page

1

1 reference

18 August 2017

J Mark Ruscin

series ordinal

2

1 reference

18 August 2017

Jacquelyn L Bainbridge

series ordinal

3

1 reference

18 August 2017

Andreas A Brieke

series ordinal

4

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

28

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

271-280

1 reference

Epidemiology of restless legs syndrome: the current status.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Clinical practice. Restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Restless legs syndrome probably induced by risperidone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Zonisamide-induced restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Alcohol use and periodic limb movements of sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

The restless legs syndrome and periodic limb movement disorder: a review of management

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Fluoxetine and restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Fluoxetine-induced sleep disturbance in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Mirtazapine may have the propensity for developing a restless legs syndrome? A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Does domperidone potentiate mirtazapine-associated restless legs syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Restless legs syndrome and paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Clinical presentation, diagnosis, and quality of life issues in restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

The restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Prevalence of restless legs syndrome and periodic limb movement disorder in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

New paradigms in the treatment of restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Validation of the Johns Hopkins restless legs severity scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

The Johns Hopkins telephone diagnostic interview for the restless legs syndrome: preliminary investigation for validation in a multi-center patient and control population

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Current guidelines and standards of practice for restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

An algorithm for the management of restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Valvular heart disease and the use of dopamine agonists for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

"Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

Antidepressant medication use and restless legs syndrome in patients presenting with insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.271

21 January 2018

Identifiers

DOI

10.1592/PHCO.28.2.271

1 reference

18 August 2017

1 reference

ResearchGate publication ID

18 August 2017

5625840

1 reference

https://www.researchgate.net/publication/5625840_Restless_Legs_Syndrome_Induced_by_Escitalopram_Case_Report_and_Review_of_the_Literature

title

Restless Legs Syndrome Induced by Escitalopram: Case Report and Review of the Literature | Request PDF (English)

Semantic Scholar paper ID

6 September 2023

409f43278482ac4c896e01c6b9fc78430c4577ac

1 reference